Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) Receivables

The latest receivables for DMAQU is $1.3M as of June 2026. That compares with $2.2M in the prior-year period — down 42.1% year over year. Investors often review this figure alongside Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, DMAQU's receivables moved from $2.2M to $1.3M — a 42.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s operating scale or balance-sheet position.

A receivables figure of $1.3M for DMAQU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DMAQU's receivables ($1.3M), review year-over-year change from $2.2M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.